Institutional Ownership
Connect Biopharma Hldgs Ltd
CUSIP 207523101ADSQ1 2026
13D / 13G Filings
28
Schedule 13D/13G on record
Beneficial Filers
14
Distinct reporting persons
Largest Stake
25.1%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
28 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Biofortune Inc. | 13G/A | 10.8% | 6.03M | SEC |
| 2 | Feb 17, 2026 | Zheng Wei | 13G/A | 9.0% | 5.02M | SEC |
| 3 | Feb 17, 2026 | Ikarian Capital, LLC | 13G | 11.0% | 4.93M | SEC |
| 4 | Nov 28, 2025 | Wei Zheng | 13G/A | 9.9% | 5.53M | SEC |
| 5 | Jul 21, 2025 | Panacea Innovation Limited | 13D/A | 25.1% | — | SEC |
| 6 | Jul 1, 2024 | Panacea Innovation Ltd | 13D/A | 24.3% | 13.41M | SEC |
| 7 | Feb 27, 2024 | Panacea Innovation Ltd | 13D/A | 21.8% | 12.00M | SEC |
| 8 | Feb 27, 2024 | Ra Capital Management, L.P. | 13D/A | — | — | SEC |
| 9 | Feb 13, 2024 | Wei Zheng | 13G/A | 11.7% | 6.49M | SEC |
| 10 | Feb 13, 2024 | Biofortune Inc | 13G/A | 11.2% | 6.16M | SEC |
18 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Connect Biopharma Hldgs Ltd.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Eversource Wealth Advisors, LLC | 1.2K | $3.3K |